Willow’s personalized medication mimics GLP-1, a naturally occurring hormone in your body that’s released by the gut in response to food.
This gives a boost to the natural response to eating food, increasing insulin release from the pancreas, slowing down the stomach emptying, and target receptors that reduce appetite.
This safe and effective treatment will help you lose weight by quieting food cravings and helping you feel fuller faster and longer. Semaglutide helped individuals lose an average of 15% of their body weight over 68 weeks in clinical studies.
Premium weight loss medication, similar to Semaglutide. The key difference is Tirzepatide targets both GLP-1 and GIP receptors, while Semaglutide targets only GLP-1. Both are weekly subcutaneous injections. Tirzepatide is more effective, with studies showing an average 22.5% body weight loss over 72 weeks, compared to 15% with Semaglutide.
“I love working with Willow patients. There’s nothing better than hearing them describe what it’s like to finally achieve their goals. Being able to be more active with their kids, feeling confident in a swim suit, or just having more energy throughout their day. I’m grateful to be able to help them on their journey.”